C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease
- PMID: 18945322
- DOI: 10.1111/j.1440-1843.2008.01403.x
C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease
Abstract
Background and objective: CRP is elevated in patients with acute exacerbations of COPD (AECOPD), but there is little information on whether this biomarker can help to identify adverse short-term clinical outcomes.
Methods: A 6-month prospective study of all patients with AECOPD requiring hospital admission. Clinical, laboratory (including plasma CRP levels at admission) and functional data were recorded. The outcome variable (the adverse outcome) consisted of: (i) death in hospital or within 15 days of discharge, (ii) transfer to the intensive care unit, or (iii) development of acute heart failure during hospitalization.
Results: Data from 147 patients with a total of 160 admissions were recorded. During follow up, 38 (23.7%) adverse outcomes were observed, including 13 (8.8%) and 8 (5.4%) patients who died during hospitalization or within 15 days of discharge, respectively. CRP at a level of 50 mg/L was related to an adverse outcome (OR 4.9, 95% CI: 1.92-12.6, P < 0.01), although by itself it was neither sensitive nor specific (area under the receiver operating characteristic curve (AUC) 0.69, 95% CI: 0.60-0.77). However, a risk score derived from the combination of CRP with other variables, such as 'current smoker', 'at least two comorbidities' and 'confusion,' at admission showed good predictive ability to identify an adverse outcome (AUC of 0.80, 95% CI: 0.72-0.88).
Conclusions: Plasma CRP in combination with other variables obtained at admission may assist identification of high-risk patients with AECOPD.
Similar articles
-
High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease.Pneumologia. 2012 Jul-Sep;61(3):160-2. Pneumologia. 2012. PMID: 23175870
-
C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.Med Princ Pract. 2008;17(3):202-8. doi: 10.1159/000117793. Epub 2008 Apr 10. Med Princ Pract. 2008. PMID: 18408388
-
The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation.Chron Respir Dis. 2009;6(3):149-55. doi: 10.1177/1479972309104660. Chron Respir Dis. 2009. PMID: 19643829
-
C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.Curr Opin Pulm Med. 2009 Mar;15(2):120-5. doi: 10.1097/MCP.0b013e3283218603. Curr Opin Pulm Med. 2009. PMID: 19532026 Review.
-
Predicting outcomes following hospitalization for acute exacerbations of COPD.QJM. 2010 Nov;103(11):817-29. doi: 10.1093/qjmed/hcq126. Epub 2010 Jul 26. QJM. 2010. PMID: 20660633 Review.
Cited by
-
Emergency department management of acute exacerbations of chronic obstructive pulmonary disease and factors associated with hospitalization.J Res Med Sci. 2014 Apr;19(4):297-303. J Res Med Sci. 2014. PMID: 25097600 Free PMC article.
-
C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis.Eur Respir Rev. 2017 Jan 31;26(143):160070. doi: 10.1183/16000617.0070-2016. Print 2017 Jan. Eur Respir Rev. 2017. PMID: 28143876 Free PMC article. Review.
-
Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis. 2013;8:151-7. doi: 10.2147/COPD.S39403. Epub 2013 Mar 24. Int J Chron Obstruct Pulmon Dis. 2013. PMID: 23658480 Free PMC article.
-
Can patients with moderate to severe acute respiratory failure from COPD be treated safely with noninvasive mechanical ventilation on the ward?Int J Chron Obstruct Pulmon Dis. 2016 May 31;11:1151-60. doi: 10.2147/COPD.S104801. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27330283 Free PMC article.
-
Clinical value of IL-13 and ECP in the serum and sputum of eosinophilic AECOPD patients.Exp Biol Med (Maywood). 2020 Aug;245(14):1290-1298. doi: 10.1177/1535370220931765. Epub 2020 Jun 3. Exp Biol Med (Maywood). 2020. PMID: 32493123 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous